March 3, 2023 Experience European Biotech Acquisition $220 million combination with Oculis We advised European Biotech Acquisition on its de-SPAC transaction
January 19, 2023 Experience Sun Pharmaceutical acquisition of Concert Pharmaceuticals We advised Sun Pharmaceutical on the transaction
December 14, 2022 Experience Priveterra Acquisition initial business combination with AEON Biopharma We are advising Priveterra on the transaction
November 15, 2022 Experience Metalmark Capital up to $50 million investment in Morgenesis We advised Metalmark on the transaction
November 9, 2022 Experience Molded Devices acquisition of GlobalMed and Schauenburg-Truplast We advised Molded Devices on the acquisition and the related financing arrangements
November 1, 2022 Experience Johnson & Johnson $16.6 billion acquisition of Abiomed We are advising J.P. Morgan Securities as financial adviser to Johnson & Johnson
October 17, 2022 Experience European Biotech Acquisition $200 million combination with Oculis We are advising European Biotech Acquisition Corp. on its deSPAC transaction
September 1, 2022 Experience Novo Nordisk $1.1 billion acquisition of Forma Therapeutics We are advising Novo Nordisk on the transaction
August 19, 2022 Experience Freeman Spogli investment in EverVet We advised Tailwind Capital and EverVet on the transaction
August 19, 2022 Experience Esco Aster spinoff transactions We are advising Esco Lifesciences on the spinoff